NLRP3 inhibitor (Viva star)

N/A

Report date: 2024/07/10 10:58:22
NME

Base Information

Drug NameNLRP3 inhibitor (Viva star)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsImmune System DiseasesAlzheimer DiseaseParkinson Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesViva Star Biosciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesViva Star Biosciences Ltd
Inactive CompaniesN/A
Active IndicationsImmune System DiseasesAlzheimer DiseaseParkinson Disease +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A